Research Article
Natural Bioactive Compounds Promote Cell Apoptosis in Gastric Cancer Treatment: Evidence from Network Pharmacological Study and Experimental Analysis
Table 3
The molecular docking results of 4 key targets with 10 potential ingredients.
| | Target (PDB ID) | Ligand | Binding energy (kcal/mol) |
| | AKT1 (6hhf) | Quercetin | −9.2 | | AKT1 (6hhf) | Ursolic acid | −8.9 | | AKT1 (6hhf) | Luteolin | −9.6 | | AKT1 (6hhf) | Formononetin | −9.3 | | AKT1 (6hhf) | Kaempferol | −9.2 | | AKT1 (6hhf) | beta-Sitosterol | −10.4 | | AKT1 (6hhf) | Wighteone | −10.0 | | AKT1 (6hhf) | Wogonin | −9.4 | | AKT1 (6hhf) | Stigmasterol | −10.7 | | AKT1 (6hhf) | Matrine | −8.3 | | TP53 (5g6o) | Quercetin | −7.9 | | TP53 (5g6o) | Ursolic acid | −7.3 | | TP53 (5g6o) | Luteolin | −8.2 | | TP53 (5g6o) | Formononetin | −8.1 | | TP53 (5g6o) | Kaempferol | −7.1 | | TP53 (5g6o) | beta-Sitosterol | −7.0 | | TP53 (5g6o) | Wighteone | −8.1 | | TP53 (5g6o) | Wogonin | −7.9 | | TP53 (5g6o) | Stigmasterol | −7.2 | | TP53 (5g6o) | Matrine | −8.0 | | CASP3 (3gjr) | Quercetin | −6.8 | | CASP3 (3gjr) | Ursolic acid | −8.7 | | CASP3 (3gjr) | Luteolin | −7.1 | | CASP3 (3gjr) | Formononetin | −7.3 | | CASP3 (3gjr) | Kaempferol | −6.7 | | CASP3 (3gjr) | beta-Sitosterol | −7.8 | | CASP3 (3gjr) | Wighteone | −7.6 | | CASP3 (3gjr) | Wogonin | −7.2 | | CASP3 (3gjr) | Stigmasterol | −7.8 | | CASP3 (3gjr) | Matrine | −8.1 | | EGFR (3lzb) | Quercetin | −8.0 | | EGFR (3lzb) | Ursolic acid | −6.7 | | EGFR (3lzb) | Luteolin | −8.0 | | EGFR (3lzb) | Formononetin | −7.6 | | EGFR (3lzb) | Kaempferol | −8.1 | | EGFR (3lzb) | beta-Sitosterol | −8.0 | | EGFR (3lzb) | Wighteone | −8.4 | | EGFR (3lzb) | Wogonin | −8.0 | | EGFR (3lzb) | Stigmasterol | −8.7 | | EGFR (3lzb) | Matrine | −8.5 |
|
|
